Merck & Co., Inc. financials
Key figures from Merck & Co., Inc.'s filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $16.6B | $15.8B | +5.1% |
| Net income | -$1.3B | $4.4B | -130.2% |
| Free cash flow | $4.5B | $2.5B | +77.0% |
| Gross margin | 73.5% | 77.5% | -4.0 pts |
| Operating margin | — | — | — |
| Net margin | -8.0% | 28.0% | -36.0 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $65.0B | $18.3B | 28.1% | $12.4B | $7.28 |
| FY Dec 2024 | $64.2B | $17.1B | 26.7% | $18.1B | $6.74 |
| FY Dec 2023 | $60.1B | $365M | 0.6% | $9.1B | $0.14 |
| FY Dec 2022 | $59.3B | $14.5B | 24.5% | $14.7B | $5.71 |
| FY Dec 2021 | $48.7B | $12.3B | 25.3% | — | $5.14 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.